Xin Li1, Yue Qin1, Shaoyu Wang2, Xiang Feng3, Yifan Qian1, Juan Tian1, Liyao Liu1, Yinhu Zhu1, Boyuan Jiang1, and Yanqiang Qiao1
1XI’AN DAXING HOSPITAL, ShaanXi, Xi’an, China, 2Siemens Healthcare Ltd., ShaanXi, Xi’an, China, 3Siemens Healthcare Ltd., Beijing, China
Synopsis
Hypertension
is known to be a major risk factor for damage to target organs, including the
brain. Hypertension may be associated with increased heme content and non-heme
iron contents. QSM is a potent imaging method that can provide a noninvasive
and accurate measurement of iron content in the brain for diagnosing diseases
and monitoring progression and treatment. This study evaluated the feasibility
of QSM in the measurement of brain iron deposition in patients with
hypertension. We found increased iron accumulation primarily in the deep gray matter nucleus in hypertensive patients.
Introduction
Hypertension is a leading cause of
global disease and overall health loss1.Excluding age,
hypertension is one of the most important risk factors for stroke and dementia.
Regional excessive iron overload contributes
to the continuous generation of radical species and toxic free radicals, which
are harmful to the motor and cognitive functions of the brain, because they interfere
with dopamine synthesis. Previous studies have detected abnormal serum ferritin
levels in patients with hypertension. Hypertension may be associated with
increased heme and non-heme iron contents beyond the normal effects of aging. Quantitative
susceptibility mapping (QSM) can accurately reflect the spatial distribution of
the tissue’s magnetic susceptibility, providing an indirect way of quantifying
iron content in the brain. Most QSM studies have focused on tumors and neurodegenerative
diseases, such as multiple sclerosis, Alzheimer’s Disease, and Parkinson’s
Disease.
However, to date, there have been few studies
that use QSM to investigate the iron content of brain tissue in patients with
hypertension. This study used QSM to examine the brain iron concentration in hypertensive patients and evaluate its association
with the severity of hypertension.Methods
We collected two groups of age- and
sex-matched participants: 24 patients with hypertension (HP, 12 males, 12 females; mean age = 65.3 ± 10.8
years) and 24 healthy controls (HC, 11 males, 13 females; mean age = 64.9 ± 10.5
years). All subjects were scanned with a 1.5T MR
scanner (MAGNETOM Aera, Siemens Healthcare, Erlangen, Germany) using a 16-channel
head coil. A multi-echo gradient echo (ME-GRE) sequence was applied for QSM acquisition
with the following parameters: repetition time (TR) = 51 ms, TE1/ΔTE/TE8
= 8.22 ms/5 ms/43.22 ms, bipolar readout, slice thickness = 2 mm, flip angle = 20°,
FOV = 230 mm × 210 mm, matrix size = 224 × 180, bandwidth
= 200 Hz/Px, and slices = 56. The magnitude and phase images from ME-GRE acquisition
were post-processed to generate susceptibility maps using the MEDI toolbox on Matlab
(R2016b, Mathworks, Natick, MA, USA).
The regions of interest at the bilateral dental nucleus (DN), dorsal thalamus (TH),
putamen (PU), globus pallidus (GP), caudate (CA), and cerebrospinal fluid (CSF)
within the lateral ventricle were manually drawn on the susceptibility maps to extract tissue susceptibility values (Fig.1). The
susceptibility values of each structure were calculated as the average of the bilateral
sides.
Statistical
analysis was performed using SPSS software (version 19.0, IBM Corp., Armonk, NY,
USA). The measurement data were expressed as mean ± standard deviation (SD).p< 0.05 was considered statistically
significant. Interobserver agreement was assessed by calculating the Cohen kappa
statistic (kappa < 0.00: poor agreement, kappa= 0.00 - 0.20: slight
agreement, kappa= 0.21 - 0.40: fair agreement, kappa= 0.40 - 0.60: moderate agreement,
kappa= 0.61 - 0.80: substantial agreement; kappa= 0.81 - 1.00: almost
complete agreement).Results
There were no significant differences
in sex or age between the two groups. The susceptibility values of the bilateral
DN,
TH, PU, GP, CA, and CSF of HP were higher than those of the HC (p< 0.05) (Table 1). The magnetic susceptibility of HP showed no
statistically significant difference in bilateral DN, TH, PU, GP, CA, and CSF, as
well as in different sexes (p> 0.05)
(Table
2,3). The interobserver agreement was high in both sequences (kappa= 0.67).Discussion
This study found that the magnetic susceptibility
of subcortical structures of hypertensive patients, such as bilateral DN, TH,
PU, GP, CA, and CSF, were higher than in healthy controls. The results
suggested that the amount of iron deposition in the brains of hypertensive
patients were overloaded. This iron overload might be caused by several factors.
Cardiovascular and cerebrovascular diseases are the most common complications
in patients with hypertension, including micro-bleeding, subcortical lacunar
infarctions, and diffuse areas of white matter lesions. Hypertension-associated
cerebral microbleeds are typically located in the basal ganglia and thalamus2. This may suggest
that iron deposition in the hypertensive brain may be related to micro-bleeding.
It is well established that QSM can be a noninvasive in vivo
quantitative measure for tissue iron. Previous studies using phase imaging or
susceptibility-weighted imaging found that abnormal iron deposition in the
brain occurred in some neuropsychiatric diseases3. Compared with phase
imaging, the QSM method provides more accurate measurements of the deposited
iron.Conclusion
We used,
for the first time, QSM to explore iron accumulation in subcortical nuclei in the
setting of hypertension. Our results indicated the role of excess brain iron in
the deep gray matter in hypertension and suggested that iron may be a potential
biomarker for further understanding the pathophysiological mechanism of hypertension.Acknowledgements
We thank Shaoyu
Wang, Xiang Feng of Siemens Healthcare, Ltd., Xi’an, China, for technical support.
References
1.Zhua Y, Chen G,
Bo Y, Liu Y. Markers of iron status, blood pressure and incident hypertension
among Chinese adults. Nutrition, metabolism, and cardiovascular diseases : NMCD
2019; 29(8): 830-836.
2.Meissner A. Hypertension and
the Brain: A Risk Factor for More Than Heart Disease. Cerebrovasc Dis 2016;
42(3-4): 255-262.
3.Chen Q, Chen Y, Zhang Y, et al.
Iron deposition in Parkinson’s disease by quantitative susceptibility mapping.
BMC Neuroscience 2019; 20(1): 23.